Formatted Title

Evaluation of CAT 100-Induced Sequestration, Reductive Dechlorination, and Biodegradation of a Mixture of Chlorinated Solvents, PFAS, and 1,4-Dioxane

Background/Objectives

The 3.85-acre confidential site, located in a heavy industrial/commercial area in New Jersey, includes an 82,500 square-foot manufacturing building where electroplating and other operations were conducted for nearly 50 years. Site investigation activities conducted from 2020 to 2021 in overburden and bedrock groundwater detected high levels of chlorinated ethenes, including trichloroethene (TCE), cis-1,2-dichloroethene, vinyl chloride, and 1,1-dichloroethene, as well as high levels of per- and polyfluorinated substances (PFAS) and 1,4-dioxane impacts to soil and groundwater. Regional geology in the vicinity of the site is characterized by an upper unit consisting of river alluvium and eolian deposits of Holocene Age, underlain by glacial unconsolidated deposits (clay, silt, sand, and gravel) of Pleistocene Age, and finally bedrock of the Passaic Formation, consisting of thin bedded shales, mudstones, and sandstones. Unconsolidated deposits at the site are comprised predominantly of glacial till. A clay layer, continuous across much of the site, is observed midway through the till from approximately 15 feet to 20 feet below the ground surface. Groundwater elevations are monitored in three zones: shallow till (5 to 20 feet below ground surface [bgs]) above the clay layer); lower till and underlying highly weathered bedrock (20 to 35 bgs); and the upper competent bedrock (60 to 80 feet bgs). 

The primary objective at the site is the reduction in mass, concentration, and mobility of chlorinated ethenes that have consistently been detected in groundwater at levels ranging from a few parts per billion to over 100 parts per million. Secondary and tertiary objectives are the sequestration of a portion of PFAS and the biodegradation of 1,4-dioxane.

Approach/Activities

Because PFAS are highly recalcitrant to in situ destruction technologies, and because chlorinated ethenes and 1,4-dioxane typically require sequential biodegradation technologies under respectively reducing and oxidizing conditions, simultaneous remediation of these target compounds is rarely attempted. However, an acceptable interim remedial approach was identified whereby Remediation Products, Inc.’s (RPI’s) Trap and Treat^® CAT 100, a proprietary mixture of virgin activated carbon impregnated with metallic iron, and a suite of complex carbohydrates, yeast extract, and bacteria, would be injected into the saturate zone to, 1) sequester a portion of the target compounds, 2) enhance the abiotic and biotic reductive dechlorination of chlorinated ethenes, and 3) persist within anaerobic/aerobic transition zones to promote the biodegradation of 1,4-dioxane. An injection design was subsequently prepared to identify the dose of CAT 100 necessary to achieve these objectives. The design was based on the collection of 667 soil samples and 144 groundwater samples over a 45,000-square-foot area where chlorinated ethenes and PFAS were detected at the highest levels. Soil samples were collected on 1 to 3 foot intervals while groundwater samples were collected from temporary shallow and deeper wells to the top of bedrock. A series of “heat” maps were generated to identify areas of concentrated impacts, and to develop the dosage of CAT 100. A total of 900 locations were tentatively identified for the injection of a total of 125,800 pounds of iron-impregnated activated carbon, 91,750 pounds of pea fiber, 4,565 pounds of yeast extract, and 245 pounds of bacteria in 214,000 gallons of water. The injection work was completed over a 6-month period during the renovation of the building.

Results/Lessons Learned

Preliminary groundwater monitoring results indicate that reducing conditions have been engendered, as planned, in all of the targeted injection areas, with over 90 percent reduction in TCE in most of the target wells. Remediation performance monitoring conducted at 30, 60, and 90 days after the completion of the injection program (November 2023), will include the full suite of chlorinated ethenes, PFAS, and 1,4-dioxane, noting trends and exceptions to plan. Complete details regarding challenges and synergies will be provided.